roginolisib
Phase 1- Indications
- Uveal melanoma, Non-small cell lung cancer, Primary myelofibrosis
Company intelligence / Profile preview
INKEF Capital
Amsterdam, Noord-Holland, Netherlandsinkef.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Phase 1
01
Overview
INKEF Capital is a leading Amsterdam-based venture capital firm specializing in early-stage investments across Europe and the US. It focuses on healthcare—including therapeutics, digital health, diagnostics, biotech—and technology sectors. The firm provides both financial backing and strategic support to its portfolio companies from seed through growth stages. Its healthcare investments span pharmaceuticals & biotech innovations such as radiopharmaceuticals for oncology and small molecule therapies for cardiovascular diseases.
- Therapeutic areas
- OncologyCardiovascularMetabolic DisordersOther
- Modalities
- Not directly applicable; as an investor they back companies working with small molecules, biologics (e.g., mAbs), digital health platforms, medical devices
- Industry
- Investors
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Notable partnerships are with their limited partners/investors such as ABP; direct pharma partnerships occur at the portfolio company level.
Beyond the preview
Go deeper on INKEF Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on INKEF Capital.